1.Date of the shareholders' meeting resolution:2018/11/14
2.Name and title of the director with permission to engage in competitive
  conduct:
Director： Wang, Hsun-Sheng
Director： Wang, Hsun-Hui
Independent Director： Chen, Hung-Shou
Independent Director： Wu, Su-Huan
Independent Director： Zhou,Yan-Peng
3.Items of competitive conduct in which the director is permitted to engage:
Director： Wang, Hsun-Sheng
Chairman of Chunghwa Chemical Synthesis & Biotech Co. Ltd.
Chairman of Chunghwa  Yuming  Healthcare Co., Ltd.
Chairman of SINO-JAPAN Chemical Co., Ltd.
Director of Suzhou Chung-Hwa Chemical& Pharmaceutical Industrial Co. Ltd.
Director： Wang, Hsun-Hui
Chairman of Suzhou Chung-Hwa Chemical& Pharmaceutical Industrial Co. Ltd.
Director of Suzhou Chunghwa Yuming Pharmaceutical Co., Ltd.
Director of Chunghwa Chemical Synthesis & Biotech Co. Ltd.
Supervisor of SINO-JAPAN Chemical Co., Ltd.
Independent Director： Chen, Hung-Shou
Founder and Chairman of OneAD Inc.
Independent Director of  Yageo Co. Ltd.
Independent Director of Giant Manufacturing Co. Ltd.
Independent Director of momo.com Inc.
Independent Director： Wu, Su-Huan
Independent Director of Iron Force Industrial  Co. Ltd.
Vice General Manager of SiEn (QingDao) Integrated Circuits Co., Ltd.
Independent Director： Zhou,Yan-Peng
Chairman of InQuartik Co. Ltd.
Founder of InQuartik 、ScienBiziP and MiiCs
Professor of Office of Research and Development
Professor of Department of Biomedical Engineering
Professor of Graduate Institute of Patent
Member of Chinese National Federation of industries
Member of The Institute for Biotechnology and Medicine Industry
4.Period of permission to engage in the competitive conduct:
2018/11/14 - 2021/11/13
5.Circumstances of the resolution (please describe the results of the voting
  under Article 209 of the Company Act):
The results of the voting :
226,990,129 shares were represented at the time of voting.
Votes for: 221,434,613votes (including 45,350,529 shares voted via
electronic transmission)
Votes against: 420,221 votes (including 420,221 shares voted via
electronic transmission)Votes invalid: 0 votes
Votes abstained: 5,135,295votes (including4,696,601
shares voted via electronic transmission)
Approval votes exceeded a certain number as specified in the Articles of
Incorporation. Hence, the proposal was approved.
6.If the permitted competitive conduct is business of a mainland China area
  enterprise, the name and title of the director (if it is not business of a
  mainland China area enterprise, please enter ”not applicable” below):
Director： Wang, Hsun-Sheng
Director：Wang, Hsun-Hui
Independent Director: Wu, Su-Huan
7.Company name of the mainland China area enterprise and the director's
  position in the enterprise:
Director： Wang, Hsun-Sheng / Director of Suzhou Chung-Hwa Chemical&
Pharmaceutical Industrial Co. Ltd.
Director：Wang, Hsun-Hui/ Chairman of Suzhou Chung-Hwa Chemical&
Pharmaceutical Industrial Co. Ltd.
Director：Wang, Hsun-Hui/ Director of Suzhou Chunghwa Yuming Pharmaceutical
Co., Ltd.
Independent Director： Wu, Su-Huan / Vice General Manager of SiEn (QingDao)
Integrated Circuits Co., Ltd.
8.Address of the mainland China area enterprise:
Suzhou Chung-Hwa Chemical& Pharmaceutical Industrial Co. Ltd.:
No. 66, Yongan Road, New District, Suzhou, Jiangsu
Suzhou Chunghwa Yuming Pharmaceutical Co., Ltd. :
No. 66, Yongan Road, New District, Suzhou, Jiangsu
SiEn (QingDao) Integrated Circuits Co., Ltd.:
401 International Cooperation Innovation Center（ICIC）, No. 2877
Tuanjie Road, West Coast NewDistrict, Qingdao, Shandong, China
9.Business items of the mainland China area enterprise:
Suzhou Chung-Hwa Chemical& Pharmaceutical Industrial Co. Ltd.:
pharmaceutical products/ Production and sale of health care products
Suzhou Chunghwa Yuming Pharmaceutical Co., Ltd. :
Chinese patent medicine / Chemical pharmaceutical agent /Chemical materials
SiEn (QingDao) Integrated Circuits Co., Ltd.:
Electronic technology / Semiconductor / integrated circuit
10.Degree of effect on the Company's finances and business:None
11.If the director has invested in the mainland China area enterprise, the
   monetary amount of the director's investment and the director's
   shareholding ratio:N/A
12.Any other matters that need to be specified:None